Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- HEMOSTASISIndependent statistical analysis of Comparison Study of Surgical Staplers for the Treatment of Hemorrhoids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01306877).
- Hemostasis With QuikClot® Radial® Pad Versus TR Band® After Transradial Artery Access: Complete Statistical AnalysisIndependent statistical analysis of Hemostasis With QuikClot® Radial® Pad Versus TR Band® After Transradial Artery Access: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HEORIndependent statistical analysis of Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Hepatitis B Booster Study in Adolescence: Complete Statistical AnalysisIndependent statistical analysis of Hepatitis B Booster Study in Adolescence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02169674).
- HEPCPRIndependent statistical analysis of Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HEPTIDESIndependent statistical analysis of Hepatitis C Translating Initiatives for Depression Into Effective Solutions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01143896).
- HER3+Independent statistical analysis of Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Herbal Treatment for Perennial Allergic Rhinitis: Complete Statistical AnalysisIndependent statistical analysis of Herbal Treatment for Perennial Allergic Rhinitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00456755).
- HERiTAgeIndependent statistical analysis of Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- HEROIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- HEROIndependent statistical analysis of Weight Loss Intervention for the Reduction of Cancer Risk and Health Disparities in Rural Ohio: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- HERO-ADHCIndependent statistical analysis of Treating Sleep Problems in VA Adult Day Health Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01259401).
- HEROES-DCBIndependent statistical analysis of Lutonix or Inpact for tHE tReatment Of fEmeropopliteal Stenosis - Drug Coated Balloon: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- HEROICIndependent statistical analysis of Health IT Generated PROs to Improve Outcomes in Cirrhosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03564626).
- Hestia2Independent statistical analysis of A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease: primary endpoint results, effect estimate with…
- HFSCSIndependent statistical analysis of High Frequency Stimulation Trials in Patients With Precision Spinal Cord Stimulator System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HHHFA in COPD Patients, With Chronic Bronchitis: Complete Statistical AnalysisIndependent statistical analysis of HHHFA in COPD Patients, With Chronic Bronchitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03959982).
- HHTIndependent statistical analysis of Feasibility and Validity of A Novel Computer Based Battery of Assessments in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HHTIndependent statistical analysis of Home-based Leg Heat Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03763331).
- HIBISCUSIndependent statistical analysis of Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- HIBISCUS IIndependent statistical analysis of A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis…
- HIDO-LIDOIndependent statistical analysis of High Dose IV Lidocaine vs Hydromorphone for Abdominal Pain in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- HIEIndependent statistical analysis of Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin’s Lymphoma or Central Nervous System (CNS) Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer: Complete Statistical AnalysisIndependent statistical analysis of High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma: Complete Statistical AnalysisIndependent statistical analysis of High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- High Dose or High Dose Frequency Study of Alglucosidase Alfa: Complete Statistical AnalysisIndependent statistical analysis of High Dose or High Dose Frequency Study of Alglucosidase Alfa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00483379).
- High Dose Oxytocin Nasal Spray for Treatment of Tinnitus: Complete Statistical AnalysisIndependent statistical analysis of High Dose Oxytocin Nasal Spray for Treatment of Tinnitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04210310).
- High Dose Vitamin D vs Standard Dose Vitamin D Study: Complete Statistical AnalysisIndependent statistical analysis of High Dose Vitamin D vs Standard Dose Vitamin D Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01988090).
- High Flow Therapy for the Treatment of Respiratory Failure in the ED: Complete Statistical AnalysisIndependent statistical analysis of High Flow Therapy for the Treatment of Respiratory Failure in the ED: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- High Frequency Impulse Therapy for Neuropathic Pain in NMOSD: Complete Statistical AnalysisIndependent statistical analysis of High Frequency Impulse Therapy for Neuropathic Pain in NMOSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04614454).
- High Intensity Interval Exercise SCI: Complete Statistical AnalysisIndependent statistical analysis of High Intensity Interval Exercise SCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04940598).
- High MAP in Septic Shock With Hypertension: Complete Statistical AnalysisIndependent statistical analysis of High MAP in Septic Shock With Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01443494).
- High Velocity Nasal Insufflation (Hi-VNI) Use in Upper Airway Surgery: Complete Statistical AnalysisIndependent statistical analysis of High Velocity Nasal Insufflation (Hi-VNI) Use in Upper Airway Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05090852).
- High Water Intake to Slow Progression of Polycystic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of High Water Intake to Slow Progression of Polycystic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00784030).
- High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML: Complete Statistical AnalysisIndependent statistical analysis of High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00774046).
- High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01266603).
- High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Complete Statistical AnalysisIndependent statistical analysis of High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): primary endpoint results, effect estimate with confidence interval, sample-size…
- High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00349778).
- High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02932332).
- High-Risk Skin Cancers With Atezolizumab Plus NT-I7: Complete Statistical AnalysisIndependent statistical analysis of High-Risk Skin Cancers With Atezolizumab Plus NT-I7: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03901573).
- Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery: primary endpoint results,…
- HIIT-SCIIndependent statistical analysis of Feasibility of HIIT in Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03152110).
- HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…